Jennifer Adair to Brain Neoplasms
This is a "connection" page, showing publications Jennifer Adair has written about Brain Neoplasms.
Connection Strength
0.909
-
Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC, Storer BE, Rockhill JK, Swanson KR, Kiem HP. Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. J Clin Invest. 2014 Sep; 124(9):4082-92.
Score: 0.367
-
Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL, Mrugala MM, Kiem HP. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Transl Med. 2012 May 09; 4(133):133ra57.
Score: 0.314
-
Mrugala MM, Adair J, Kiem HP. Chemoprotection in glioblastoma therapy: reality or a dream? CNS Oncol. 2012 Sep; 1(1):11-4.
Score: 0.080
-
Mrugala MM, Adair JE, Kiem HP. Outside the box--novel therapeutic strategies for glioblastoma. Cancer J. 2012 Jan-Feb; 18(1):51-8.
Score: 0.077
-
Mrugala MM, Adair J, Kiem HP. Temozolomide: Expanding its role in brain cancer. Drugs Today (Barc). 2010 Nov; 46(11):833-46.
Score: 0.071